Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer.

Trial Profile

Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2012

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Breast cancer; Early breast cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 08 Feb 2010 Status changed from recruiting to completed.
    • 01 Jan 2010 Primary endpoint results published in the Breast Cancer Research and Treatment 119: 137-144, No. 1, 1 Jan 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top